Orchid Pharma, backed by Dhanuka Group, focuses on cephalosporin antibiotics. Expansion plans include a new facility, Enmetazobactam launch, and mergers for sustainable growth and reduced import reliance.
Copyright © 2024 | WordPress Theme by MH Themes